Trimel Pharmaceuticals Corporation to Report Third Quarter 2011 Results and Host a Conference Call

(firmenpresse) - TORONTO, CANADA -- (Marketwire) -- 10/27/11 -- Trimel Pharmaceuticals Corporation (TSX: TRL) will report on the third quarter results for the Company and its subsidiaries for the period ended September 30, 2011 on Wednesday, November 2, 2011 after the market closes.

Management of the Company will host a conference call to discuss these results on Thursday, November 3, 2011, at 8:30 a.m. Eastern Time. Presenting from Trimel will be Bruce Brydon, Chairman of the Board and Chief Executive Officer, and Kenneth Howling, Chief Financial Officer.

To access the call live, please dial 416-340-2219 (Toronto), 1-866-226-1798 (Canada and U.S.), and 00-800-9559-6849 (International). Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays.

A replay of the conference call will be available until 7:00 p.m. Eastern Time on Thursday, November 10, 2011 by dialing 905-694-9451 (Toronto), 1-800-408-3053 (Canada and U.S.) or 00-800-3366-3052 (International), using access code: 4012435#.

For further information regarding Trimel Pharmaceuticals Corporation, please contact either Bruce Brydon at 416-679-0711 or Kenneth Howling at 416-679-0536 or via email at .

About Trimel

Trimel Pharmaceuticals Corporation (TSX: TRL) - Developing medications for Female Sexual Health and conditions related to Aging, and Well Being. Trimel is developing multiple product opportunities, including CompleoTRT, a bio-adhesive intranasal Testosterone gel for the treatment of male hypogonadism, a condition commonly referred to as "Low T". For more information, please visit .



Contacts:
Trimel Pharmaceuticals Corporation
Kenneth G. Howling
Chief Financial Officer
416 679 0536

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 27.10.2011 - 17:00 Uhr
Sprache: Deutsch
News-ID 81163
Anzahl Zeichen: 0

contact information:
Town:

TORONTO, CANADA

Kategorie:

Healthcare

Diese Pressemitteilung wurde bisher 193 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Trimel Pharmaceuticals Corporation to Report Third Quarter 2011 Results and Host a Conference Call"
steht unter der journalistisch-redaktionellen Verantwortung von

Trimel Pharmaceuticals Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Trimel Announces Filing of NATESTO(TM) With Health Canada ...

TORONTO, ONTARIO -- (Marketwired) -- 01/26/15 -- Trimel Pharmaceuticals Corporation (TSX: TRL) today announced that it has filed a New Drug Submission with Health Canada for NATESTO™ (testosterone) nasal gel for replacement therapy in men for cond ...

Trimel Announces Closing of Exclusive Agreement for NATESTO(TM) ...

TORONTO, ONTARIO -- (Marketwired) -- 12/09/14 -- Trimel Pharmaceuticals Corporation (TSX: TRL) today announced the closing of the previously communicated agreement between its subsidiary, Trimel BioPharma SRL, and an affiliate of Endo International ...

Trimel Announces Issuance of Additional Patent Covering NATESTO(TM) ...

TORONTO, ONTARIO -- (Marketwired) -- 11/25/14 -- Trimel Pharmaceuticals Corporation (TSX: TRL) today announced that its technology partner Mattern Pharma AG has been granted an additional United States Patent in respect of NATESTO™ and its propri ...

Alle Meldungen von Trimel Pharmaceuticals Corporation